Delivery Order SPE2DB20D2104-SPE2DB24FS31P
- Not listed
- This federal contract award, valued at $2,421.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,563,803,656 units of Cetirizine HCL 5 mg tablets. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC enables Cencora, Inc. to efficiently deliver a...
- This federal contract award, with ID SPE2DB20D2002|SPE2DB24FL12P, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,512.19 firm-fixed-price delivery order is for the procurement of 4,563,188,582 units of the pharmaceutical drug Cetirizine HCL 5 mg tablets. The contract has an ultimate completion date of December 28, 2023 and was awarded on December 27, 2023. It was not designated as a set-aside contract. Amerisourcebergen Drug...
- This federal contract award, valued at $1,127.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Cetirizine HCL 5 mg tablets in 100-count bottles, with a completion date of May 6, 2024. This contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to $999,999,999.00 and expiring in November 2026. The IDC serves as the...
- This federal contract award, valued at $2,051.14, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,566,674,952 units of Cetirizine HCL 10 mg tablets, a pharmaceutical product used for various medical purposes. The contract has a completion date of December 11, 2024 and utilizes a firm fixed-price pricing structure. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,046.97 firm fixed-price delivery order is for the supply of 4,567,707,523 units of Cetirizine HCL 10 mg tablets, with a performance period through March 27, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,108.38 firm fixed-price delivery order is for the supply of 4,562,252 units of Cetirizine HCL 10 mg tablets. The award has a completion date of September 21, 2023 and was made under the company's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,172.80 firm fixed-price delivery order is for the supply of Cetirizine HCL 5 mg tablets, with a completion date of December 18, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award, valued at $4,702.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,073,284 units of Cetirizine HCL 10 mg tablets, a prescription medication, with a completion date of April 30, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,696.62 Firm Fixed Price Delivery Order contract is for the supply of Cetirizine HCL 10 mg Tablets. No set-aside designation was used. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Delivery Order contract, valued at $1,188.32, is for the supply of Cetirizine HCL 5 mg Tablets in 100-count packages. The contract has an ultimate completion date of October 17, 2023, and is a Firm Fixed Price type. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS31PDelivery Order
This federal contract award, with ID SPE2DB20D2104|SPE2DB24FS31P, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,407.16 firm fixed-price delivery order is for the supply of 4,563,489,694 units of Cetirizine HCL 10 MG Tablets, a pharmaceutical product. This award is not associated with a set-aside program. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support the healthcare needs of the Department of Defense and other federal agencies. Cencora, Inc. also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/30/24 |